CBUS

What one share of Cibus holds

Agricultural Chemicals

Cibus is a leading agricultural biotechnology company that primarily uses proprietary gene editing technologies to develop plant traits, which are specific genetic characteristics in the DNA of a plant’s seed. Plant traits, or characteristics, influence how a resulting plant functions and/or interacts with its environment.

Cibus’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.07
Profit−$1.59
Capex (buildings and equipment)$0.00
Free cash flow−$0.75
Cash and investments$0.27
Debt$0.01
Book value$0.19

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2015—−$43.78$4.94−$54.69—$180.33
2016—−$30.83$26.59−$50.16—$33.47
2017—−$56.10$1.68−$29.29—$103.68
2018—−$45.46$3.01−$35.93—$143.03
2019—−$60.37$4.53−$53.22—$94.85
2020—−$66.16$2.64−$67.08—$49.74
2021—−$38.96$0.66−$25.76—$18.22
2022$0.17−$18.36$1.65−$22.70—$7.40
2023$0.18−$25.95$0.42−$4.90——
2024$0.18−$10.83$0.03−$2.53—$3.11
2025$0.08−$2.78$0.01−$1.12—$0.48

Common questions about Cibus

How much does one share of Cibus earn?

Over the last 12 months, Cibus lost $1.59 for each share on $0.07 of sales.

Does Cibus pay a dividend?

Cibus didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Cibus’s book value per share?

Cibus’s book value is $0.19 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Cibus have?

Each share of Cibus has $0.27 of cash and investments and $0.01 of debt, as of June 30, 2026.

What is Cibus’s free cash flow per share?

−$0.75 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

Has Cibus bought back shares?

Cibus’s share count rose about 33917% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.